Skip to content
★ Sign in to follow
JA

James A. Hayward

Applied DNA Sciences Inc
Total declarations
12
Company
1
▲ Purchases (8 ops.)
€252k
▼ Sales (0 ops.)
—

Latest filing published 16 Sept 2019 for APPLIED DNA SCIENCES INC, €1.4M.

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

Closed purchases

Market purchases
8

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 20 Nov 2014 · 4371 days ago · €199k
    +26.2%
    Entry US$1,512,000.00 · Close at T+365 US$1,908,000.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

James A. Hayward: trading record in brief

This profile gathers the share dealings of James A. Hayward in Applied DNA Sciences Inc. Over a trading history stretching from 4 November 2005 to 12 September 2019, the count stands at 12 filings.

No open-market sale appears; the market trades are 8 purchases worth €252k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 share grants.

The median purchase comes to €1,565.

Most recently, on 16 September 2019, the filings show a share grant worth €1.4M in Applied DNA Sciences Inc. The last purchase on record was published on 20 November 2014, which is 4,371 days ago. Filings reach the SEC (Form 4) feed a median of 31 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to James A. Hayward

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    2M USD0SEC
    2,935,764 shares@ US$0.54Common StockSEC:0001144204-19-044703:0
  • ◆
    Chairman, CEO, and PresidentExecutivesApplied DNA Sciences Inc
    100,000 USD30SEC
    370,371 shares@ US$0.27100.0% of flowCommon StockSEC:0001144204-19-041671:0
  • ◆
    Chairman, CEO, and PresidentExecutivesApplied DNA Sciences Inc
    250,001 USD29SEC
    142,046 shares@ US$1.7670.9% of flowCommon StockSEC:0001571049-17-006368:0
  • ●
    Chairman, CEO and PresidentExecutivesApplied DNA Sciences Inc
    0SEC
    315,171 sharesCommon StockSEC:0001571049-14-006678:0
  • ▲
    Chairman, CEO and PresidentExecutivesApplied DNA Sciences Inc
    249,231 USD0SEC
    76,923 shares@ US$3.24Common StockSEC:0001571049-14-006678:1
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    203 USD0SEC
    500 shares@ US$0.405Common Stock, $.001 par valueSEC:0001282695-06-000348:0
    Canonical exit: 2 Feb 2006 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    1,823 USD0SEC
    4,500 shares@ US$0.405Common Stock, $.001 par valueSEC:0001282695-06-000348:1
    Canonical exit: 2 Feb 2006 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    100 USD0SEC
    500 shares@ US$0.20Common Stock, $.001 par valueSEC:0001282695-06-000348:2
    Canonical exit: 21 Jun 2006 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    1,900 USD0SEC
    9,500 shares@ US$0.20Common Stock, $.001 par valueSEC:0001282695-06-000348:3
    Canonical exit: 21 Jun 2006 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    1,850 USD0SEC
    10,000 shares@ US$0.185Common Stock, $.001 par valueSEC:0001282695-06-000348:4
    Canonical exit: 28 Jun 2006 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    30,420 USD0SEC
    234,000 shares@ US$0.13Common Stock, $.001 par valueSEC:0001282695-06-000348:5
    Canonical exit: 9 Oct 2006 (T+90)
  • ▲
    Chief Executive OfficerExecutivesApplied DNA Sciences Inc
    30,472 USD0SEC
    234,400 shares@ US$0.13Common Stock, $.001 par valueSEC:0001282695-06-000325:0
    Canonical exit: 9 Oct 2006 (T+90)

12 of 12 declarations